Crossmark

Engineering of Corynebacterium glutamicum for biosynthesis of the pharmaceutically active N-acetyltyramine: establishing and optimizing de novo production

Crossref DOI link: https://doi.org/10.1186/s13036-026-00713-1

Published Online: 2026-06-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Poethe, Sara-Sophie https://orcid.org/0000-0001-6697-7971
Kaimann, Lilli Sophie

Schülke, Kai H. https://orcid.org/0000-0003-3486-5400
Hammer, Stephan C. https://orcid.org/0000-0002-3620-9362
Wendisch, Volker F. https://orcid.org/0000-0003-3473-0012
Funding

Funding for this research was provided by:

Universität Bielefeld
License Information

Text and Data Mining valid from 2026-06-18

Version of Record valid from 2026-06-18
More Information

Article History

Received: 5 May 2026

Accepted: 8 June 2026

First Online: 18 June 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below